What is the conversion rate from Butrans (buprenorphine) to fentanyl for a hospice patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Butrans (Buprenorphine) to Fentanyl Patch in Hospice Patients

For hospice patients converting from Butrans (buprenorphine) to fentanyl patch, use a 1:80 conversion ratio (buprenorphine mcg/hr to fentanyl mcg/hr), which is more accurate than the traditional 1:100 ratio in elderly hospice populations. 1

Conversion Algorithm

Step 1: Calculate Current Buprenorphine Dose

  • Identify the current Butrans patch strength in mcg/hr 1
  • Note: Butrans patches come in 5,10,15, and 20 mcg/hr strengths

Step 2: Apply the 1:80 Conversion Ratio

  • Divide the buprenorphine dose by 80 to determine the equivalent fentanyl patch dose 1
  • Example: A patient on Butrans 20 mcg/hr would convert to fentanyl 25 mcg/hr (20 ÷ 80 = 0.25, rounded to nearest available patch strength)
  • This 1:80 ratio is specifically validated in elderly hospice patients and appears more accurate than the traditional 1:100 ratio 1

Step 3: Reduce for Incomplete Cross-Tolerance

  • Reduce the calculated fentanyl dose by 25-50% to account for incomplete cross-tolerance and patient variability 2
  • This reduction is critical when converting between different opioids 2

Step 4: Patch Application Timing

  • Apply the fentanyl patch and continue the Butrans patch for 12-24 hours, as fentanyl levels take 12-16 hours to reach therapeutic levels 3
  • Remove the Butrans patch after 12-24 hours once fentanyl absorption is established 3

Critical Considerations for Hospice Patients

Cachectic Patients

  • Anticipate the need for 25-50% higher fentanyl patch doses in cachectic hospice patients due to impaired absorption 4
  • Monitor closely at 48-72 hours and consider more frequent patch changes (every 48 hours instead of 72 hours) if pain control wanes 4

Breakthrough Medication

  • Prescribe immediate-release opioid breakthrough medication, particularly during the first 8-24 hours after fentanyl patch application 4
  • Fentanyl levels continue rising during this initial period, requiring available rescue medication 4

Safety Precautions

  • Fentanyl patches should only be used in opioid-tolerant patients (patients already on Butrans qualify) 4
  • Heat application is absolutely contraindicated as it accelerates absorption and can cause fatal overdose 4

Monitoring and Titration

  • Reassess pain control at 48-72 hours after conversion 4
  • Use clinical judgment for dose titration, as patient variability requires individualized approaches 4
  • No difference in survival has been demonstrated between transdermal fentanyl and buprenorphine in elderly hospice populations 1

Common Pitfall to Avoid

The most significant error is using the traditional 1:100 buprenorphine-to-fentanyl conversion ratio, which results in underdosing in elderly hospice patients. The 1:80 ratio provides more accurate equianalgesia in this specific population 1, though you must still reduce by 25-50% for cross-tolerance 2.

References

Guideline

Fentanilo Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fentanyl Patch Dosing Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.